MAPT and Alzheimer disease: In AD, p-tau in blood is expected to be a continual secretion in response to extracellular Aβ plaques and intracellular tau tangles, pathologies that develop over many decades and are unlikely to be ubiquitously present in the age group of patients included in this study.